Table 2

Results of multiple logistic regression analysis for unfavourable (mRS ≥2) and poor (mRS ≥3) outcome in all patients and four subgroups

All patientsBZ groupML groupLT groupSL group
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
Model 1, mRS ≥2
 FVH (+)3.02 (1.49 to 6.13)0.0024.22 (1.25 to 14.25)0.0215.44 (1.41 to 20.92)0.0141.95 (0.24 to 15.90)0.5310.24 (0.01 to 7.36)0.410
 Male2.00 (0.86 to 4.66)0.1100.20 (0.02 to 2.12)0.1800.91 (0.17 to 4.99)0.9118.74 (0.31 to 246.91)0.2033.55 (0.49 to 25.78)0.211
 Age1.00 (0.97 to 1.03)0.8701.01 (0.96 to 1.08)0.6541.02 (0.96 to 1.09)0.4480.97 (0.89 to 1.06)0.4991.01 (0.93 to 1.11)0.761
 Occlusion1.67 (0.77 to 3.59)0.1921.14 (0.97 to 1.33)0.1030.58 (0.15 to 2.18)0.42020.51 (1.69 to 248.68)0.0181.08 (0.03 to 33.89)0.965
 NIHSS-ad1.18 (1.09 to 1.28)<0.00114.19 (1.40 to 143.85)0.0251.24 (1.06 to 1.46)0.0071.24 (0.96 to 1.60)0.0931.03 (0.72 to 1.46)0.882
Model 2, mRS ≥3
 FVH (+)2.25 (1.01 to 4.97)0.0465.52 (0.98 to 31.07)0.0534.09 (1.04 to 16.16)0.0451.53 (0.16 to 14.40)0.709NANA
 Male1.40 (0.54 to 3.62)0.4880.30 (0.02 to 3.94)0.3630.56 (0.09 to 3.58)0.5378.48 (0.33 to 217.26)0.1970.70 (0.08 to 6.26)0.754
 Age1.00 (0.97 to 1.03)0.9371.05 (0.96 to 1.14)0.3381.03 (0.97 to 1.09)0.3180.88 (0.77 to 1.00)0.0511.04 (0.93 to 1.16)0.511
 Occlusion2.90 (1.32 to 6.37)0.00832.43 (3.21 to 327.27)0.0032.10 (0.57 to 7.82)0.2685.39 (0.54 to 54.04)0.1520.01 (0.01 to 999.99)0.999
 NIHSS-ad1.21 (1.11 to 1.31)<0.0011.34 (1.07 to 1.68)0.0101.14 (1.02 to 1.27)0.0191.69 (1.18 to 2.44)0.0041.30 (0.83 to 2.02)0.253
  • Model 1 used mRS ≥2 as dependent variable; model 2 used mRS ≥3 as dependent variable.

  • The bolded entries mean significance.

  • BZ group, border-zone infarct group; FVH, fluid-attenuated inversion recovery vascular hyperintensity; LT group, large territory infarct group; ML group, multiple lesion infarcts group; mRS, modified Rankin Scale; NA, not available; NIHSS-ad, National Institute of Healthy Stroke Scale at admission; SL group, single cortical or subcortical lesion group.